BioBlog

World Cancer Day, February 4, 2020, was marked by many organizations releasing updates, news, and guidelines. WHO urged nations to improve cancer care protocols for their citizens. NCCN recognized progress but reminded the world that cancer remains the second leading cause of death. This and more in

In this edition of the Innovation Partners BioBlog, several promising cancer treatments are in the spotlight. CMS approves Medicare coverage of NGS tests for inherited ovarian and breast cancer. A new team supported by $3 million in grants seeks earlier detection methods for gastric cancer. Blue

This week, new treatments for liver, prostate, and lung cancer are featured in the Innovation Partners BioBlog. Each offers hope and a promising development in the development of oncology treatments. The Supreme Court is urged to take another look at the Texas appeals court ruling on the ACA, and

This week’s Innovation Partners BioBlog takes a look at several important stories. California Governor Newsom announced a plan to work with generic drug makers to lower costs of medications for residents. New therapies for ovarian cancer and high cholesterol are in the works. A look at the potential

You’ve heard the expression “all things old are new again” and it applies to cancer therapies, too. Drug developers are testing antibody-drug conjugates again. German manufacturer Boehringer has been clear to manufacture drugs in China, passing Chinese regulatory hurdles. The ACA is in the spotlight

Happy New Year! In this issue of the Innovation Partners BioBlog, we focus on the five top stories to watch in 2020 plus updates on new breast cancer treatments. Surprise billing, high drug prices, and the debate over Obama Care continue to lead news coverage for the health industry. Read more in

Happy New Year! We wish everyone a happy, healthy, and prosperous New Year. Here’s to a wonderful 2020! In this week’s Innovation Partners BioBlog, we update a few of 2019’s top stories regarding the ACA and proposals to lower the cost of prescription drugs. A new partnership between

Happy Holidays from Innovation Partners! We hope everyone has a lovely holiday and a Happy New Year. We’re heading into an election year, and that means that several bills on Capitol Hill may be stalled until after November. Lobbyists continue to meet with lawmakers about Nancy Pelosi’s drug pricing